Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 218 entries
Sorted by: Best Match Show Resources per page
Managing diversity in civil service: A conceptual framework for public organizations

diversity

Ospina S.
GSID: 4BRosgvrsr4J
S Ospina - Managing diversity in the civil service, 2001 - Citeseer

The new century has been marked by a generalized sense that traditional work arrangements are inadequate to address the challenges organizations encounter today. The …

Cite
Ospina, S. (2001). Managing diversity in civil service: A conceptual framework for public organizations. Managing diversity in the civil service, 1, 1-29.
Ospina, Sonia. "Managing diversity in civil service: A conceptual framework for public organizations." Managing diversity in the civil service 1 (2001): 1-29.
Copy Download .nbib Format: MLA
Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Despiégel N, Marcellin AG, Aubin C, Espinas C, Laurisse A, Pialoux G.
PMID: 27202502
Value Health. 2014 Nov;17(7):A678-9. doi: 10.1016/j.jval.2014.08.2526. Epub 2014 Oct 26.

No abstract available.

Cite
Despiégel N, Marcellin AG, Aubin C, et al. Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France. Value Health. 2014;17(7):A678-9doi: 10.1016/j.jval.2014.08.2526.
Despiégel, N., Marcellin, A. G., Aubin, C., Espinas, C., Laurisse, A., & Pialoux, G. (2014). Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A678-9. https://doi.org/10.1016/j.jval.2014.08.2526
Despiégel, N, et al. "Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A678-9. doi: https://doi.org/10.1016/j.jval.2014.08.2526
Despiégel N, Marcellin AG, Aubin C, Espinas C, Laurisse A, Pialoux G. Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France. Value Health. 2014 Nov;17(7):A678-9. doi: 10.1016/j.jval.2014.08.2526. Epub 2014 Oct 26. PMID: 27202502.
Copy Download .nbib Format: NLM
Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

Frontiers in pharmacology

Romano A, Giallongo C, La Cava P, Parrinello NL, Chiechi A, Vetro C, Tibullo D, Di Raimondo F, Liotta LA, Espina V, Palumbo GA.
PMID: 28491035
Front Pharmacol. 2017 Apr 26;8:204. doi: 10.3389/fphar.2017.00204. eCollection 2017.

Azacytidine (5-AZA) is the standard first-choice treatment for high-risk myelodysplasia (MDS) patients. However, the clinical outcome for those patients who interrupt treatment or whose disease failed to respond is very poor. In order to identify the cellular pathways that...

Cite
Romano A, Giallongo C, La Cava P, et al. Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia. Front Pharmacol. 2017;8:204doi: 10.3389/fphar.2017.00204.
Romano, A., Giallongo, C., La Cava, P., Parrinello, N. L., Chiechi, A., Vetro, C., Tibullo, D., Di Raimondo, F., Liotta, L. A., Espina, V., & Palumbo, G. A. (2017). Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia. Frontiers in pharmacology, 8204. https://doi.org/10.3389/fphar.2017.00204
Romano, Alessandra, et al. "Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia." Frontiers in pharmacology vol. 8 (2017): 204. doi: https://doi.org/10.3389/fphar.2017.00204
Romano A, Giallongo C, La Cava P, Parrinello NL, Chiechi A, Vetro C, Tibullo D, Di Raimondo F, Liotta LA, Espina V, Palumbo GA. Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia. Front Pharmacol. 2017 Apr 26;8:204. doi: 10.3389/fphar.2017.00204. eCollection 2017. PMID: 28491035; PMCID: PMC5405131.
Copy Download .nbib Format: NLM
Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses.

PeerJ

Espina M, Jülke H, Brehm W, Ribitsch I, Winter K, Delling U.
PMID: 27019778
PeerJ. 2016 Mar 22;4:e1773. doi: 10.7717/peerj.1773. eCollection 2016.

Background. Mesenchymal stromal cells (MSCs) are increasingly used for clinical applications in equine patients. For MSC isolation and expansion, a laboratory step is mandatory, after which the cells are sent back to the attending veterinarian. Preserving the biological properties...

Cite
Espina M, Jülke H, Brehm W, et al. Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses. PeerJ. 2016;4:e1773doi: 10.7717/peerj.1773.
Espina, M., Jülke, H., Brehm, W., Ribitsch, I., Winter, K., & Delling, U. (2016). Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses. PeerJ, 4e1773. https://doi.org/10.7717/peerj.1773
Espina, Miguel, et al. "Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses." PeerJ vol. 4 (2016): e1773. doi: https://doi.org/10.7717/peerj.1773
Espina M, Jülke H, Brehm W, Ribitsch I, Winter K, Delling U. Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses. PeerJ. 2016 Mar 22;4:e1773. doi: 10.7717/peerj.1773. eCollection 2016. PMID: 27019778; PMCID: PMC4806605.
Copy Download .nbib Format: NLM
16S and 23S plastid rDNA phylogenies of Prototheca species and their auxanographic phenotypes.

Journal of phycology

Ewing A, Brubaker S, Somanchi A, Yu E, Rudenko G, Reyes N, Espina K, Grossman A, Franklin S.
PMID: 25937672
J Phycol. 2014 Aug;50(4):765-9. doi: 10.1111/jpy.12209.

Because algae have become more accepted as sources of human nutrition, phylogenetic analysis can help resolve the taxonomy of taxa that have not been well studied. This can help establish algal evolutionary relationships. Here, we compare Auxenochlorella protothecoides and...

Cite
Ewing A, Brubaker S, Somanchi A, et al. 16S and 23S plastid rDNA phylogenies of Prototheca species and their auxanographic phenotypes. J Phycol. 2014;50(4):765-9doi: 10.1111/jpy.12209.
Ewing, A., Brubaker, S., Somanchi, A., Yu, E., Rudenko, G., Reyes, N., Espina, K., Grossman, A., & Franklin, S. (2014). 16S and 23S plastid rDNA phylogenies of Prototheca species and their auxanographic phenotypes. Journal of phycology, 50(4), 765-9. https://doi.org/10.1111/jpy.12209
Ewing, Aren, et al. "16S and 23S plastid rDNA phylogenies of Prototheca species and their auxanographic phenotypes." Journal of phycology vol. 50,4 (2014): 765-9. doi: https://doi.org/10.1111/jpy.12209
Ewing A, Brubaker S, Somanchi A, Yu E, Rudenko G, Reyes N, Espina K, Grossman A, Franklin S. 16S and 23S plastid rDNA phylogenies of Prototheca species and their auxanographic phenotypes. J Phycol. 2014 Aug;50(4):765-9. doi: 10.1111/jpy.12209. PMID: 25937672; PMCID: PMC4373152.
Copy Download .nbib Format: NLM
Protein pathway analysis in Clinical Proteomics using protein microarrays.

Drug discovery today. Technologies

Geho DH, Espina V, Wulfkuhle J, Petricoin EF, Liotta LA.
PMID: 24982012
Drug Discov Today Technol. 2005;2(4):353-9. doi: 10.1016/j.ddtec.2005.11.008.

Molecular diagnostics research within the field of cancer is increasingly focused on detecting low-abundance protein endpoints that can be used to define a patient's disease more completely. Protein microarrays represent an important Clinical Proteomics tool for directly measuring protein...

Cite
Geho DH, Espina V, Wulfkuhle J, et al. Protein pathway analysis in Clinical Proteomics using protein microarrays. Drug Discov Today Technol. 2005;2(4):353-9doi: 10.1016/j.ddtec.2005.11.008.
Geho, D. H., Espina, V., Wulfkuhle, J., Petricoin, E. F., & Liotta, L. A. (2005). Protein pathway analysis in Clinical Proteomics using protein microarrays. Drug discovery today. Technologies, 2(4), 353-9. https://doi.org/10.1016/j.ddtec.2005.11.008
Geho, David H, et al. "Protein pathway analysis in Clinical Proteomics using protein microarrays." Drug discovery today. Technologies vol. 2,4 (2005): 353-9. doi: https://doi.org/10.1016/j.ddtec.2005.11.008
Geho DH, Espina V, Wulfkuhle J, Petricoin EF, Liotta LA. Protein pathway analysis in Clinical Proteomics using protein microarrays. Drug Discov Today Technol. 2005;2(4):353-9. doi: 10.1016/j.ddtec.2005.11.008. PMID: 24982012.
Copy Download .nbib Format: NLM
Hepatitis A Synthetic Peptide VP3(110-121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers.

Journal of colloid and interface science

Sospedra P, Alsina MA, Espina M, Reig F, Haro I, Mestres C.
PMID: 10631024
J Colloid Interface Sci. 2000 Jan 15;221(2):230-235. doi: 10.1006/jcis.1999.6585.

To prepare liposomes containing a synthetic hepatitis A virus antigen (HAV) [VP3(110-121)] as a vaccine, the miscibility of this peptide (with negative net charge) with a neutral lipid [dipalmitoylphosphatidylcholine (DPPC)], a negatively charged lipid [dipalmitoylphosphatidylglycerol (DPPG)], and a positively...

Cite
Sospedra P, Alsina MA, Espina M, et al. Hepatitis A Synthetic Peptide VP3(110-121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers. J Colloid Interface Sci. 2000;221(2):230-235doi: 10.1006/jcis.1999.6585.
Sospedra, P., Alsina, M. A., Espina, M., Reig, F., Haro, I., & Mestres, C. (2000). Hepatitis A Synthetic Peptide VP3(110-121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers. Journal of colloid and interface science, 221(2), 230-235. https://doi.org/10.1006/jcis.1999.6585
Sospedra, et al. "Hepatitis A Synthetic Peptide VP3(110-121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers." Journal of colloid and interface science vol. 221,2 (2000): 230-235. doi: https://doi.org/10.1006/jcis.1999.6585
Sospedra P, Alsina MA, Espina M, Reig F, Haro I, Mestres C. Hepatitis A Synthetic Peptide VP3(110-121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers. J Colloid Interface Sci. 2000 Jan 15;221(2):230-235. doi: 10.1006/jcis.1999.6585. PMID: 10631024.
Copy Download .nbib Format: NLM
Quantitative evaluation of spatial coherence of the electron beam from low temperature field emitters.

Physical review letters

Cho B, Ichimura T, Shimizu R, Oshima C.
PMID: 15245108
Phys Rev Lett. 2004 Jun 18;92(24):246103. doi: 10.1103/PhysRevLett.92.246103. Epub 2004 Jun 16.

By using multiwalled carbon nanotubes as an element of a nanobiprism, we evaluated quantitatively the coherence of electrons emitted from tungsten tips at room temperature and 78 K, and found an enhancement of coherence at 78 K. The increase...

Cite
Cho B, Ichimura T, Shimizu R, et al. Quantitative evaluation of spatial coherence of the electron beam from low temperature field emitters. Phys Rev Lett. 2004;92(24):246103doi: 10.1103/PhysRevLett.92.246103.
Cho, B., Ichimura, T., Shimizu, R., & Oshima, C. (2004). Quantitative evaluation of spatial coherence of the electron beam from low temperature field emitters. Physical review letters, 92(24), 246103. https://doi.org/10.1103/PhysRevLett.92.246103
Cho, B, et al. "Quantitative evaluation of spatial coherence of the electron beam from low temperature field emitters." Physical review letters vol. 92,24 (2004): 246103. doi: https://doi.org/10.1103/PhysRevLett.92.246103
Cho B, Ichimura T, Shimizu R, Oshima C. Quantitative evaluation of spatial coherence of the electron beam from low temperature field emitters. Phys Rev Lett. 2004 Jun 18;92(24):246103. doi: 10.1103/PhysRevLett.92.246103. Epub 2004 Jun 16. PMID: 15245108.
Copy Download .nbib Format: NLM
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability.

Proteomics. Clinical applications

Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA.
PMID: 20871745
Proteomics Clin Appl. 2009 Aug 01;3(8):874-882. doi: 10.1002/prca.200800001.

Instability of tissue protein biomarkers is a critical issue for molecular profiling. Pre-analytical variables during tissue procurement, such as time delays during which the tissue remains stored at room temperature, can cause significant variability and bias in downstream molecular...

Cite
Espina V, Mueller C, Edmiston K, et al. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl. 2009;3(8):874-882doi: 10.1002/prca.200800001.
Espina, V., Mueller, C., Edmiston, K., Sciro, M., Petricoin, E. F., & Liotta, L. A. (2009). Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics. Clinical applications, 3(8), 874-882. https://doi.org/10.1002/prca.200800001
Espina, Virginia, et al. "Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability." Proteomics. Clinical applications vol. 3,8 (2009): 874-882. doi: https://doi.org/10.1002/prca.200800001
Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl. 2009 Aug 01;3(8):874-882. doi: 10.1002/prca.200800001. PMID: 20871745; PMCID: PMC2944287.
Copy Download .nbib Format: NLM
Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals.

Journal of sports medicine & doping studies

Luchini A, Tamburro D, Magni R, Fredolini C, Espina V, Bosch J, Garaci E, Petricoin EF, Liotta LA.
PMID: 24014257
J Sports Med Doping Stud. 2012;2(6). doi: 10.4172/2161-0673.1000e127.

Urine represents a valuable biofluid for noninvasive measurement of Human Growth Hormone (HGH) secretion. Unfortunately, currently available commercial HGH immunoassays do not achieve the sensitivity needed for urinary HGH measurement in the low picogram per milliliter range, the expected...

Cite
Luchini A, Tamburro D, Magni R, et al. Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals. J Sports Med Doping Stud. 2012;2(6)doi: 10.4172/2161-0673.1000e127.
Luchini, A., Tamburro, D., Magni, R., Fredolini, C., Espina, V., Bosch, J., Garaci, E., Petricoin, E. F., & Liotta, L. A. (2012). Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals. Journal of sports medicine & doping studies, 2(6), . https://doi.org/10.4172/2161-0673.1000e127
Luchini, Alessandra, et al. "Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals." Journal of sports medicine & doping studies vol. 2,6 (2012). doi: https://doi.org/10.4172/2161-0673.1000e127
Luchini A, Tamburro D, Magni R, Fredolini C, Espina V, Bosch J, Garaci E, Petricoin EF, Liotta LA. Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals. J Sports Med Doping Stud. 2012;2(6). doi: 10.4172/2161-0673.1000e127. PMID: 24014257; PMCID: PMC3761369.
Copy Download .nbib Format: NLM
Revisiting the thermal decomposition of layered gamma-titanium phosphate and structural elucidation of its intermediate phases.

Inorganic chemistry

García-Granda S, Khainakov SA, Espina A, García JR, Castro GR, Rocha J, Mafra L.
PMID: 20170087
Inorg Chem. 2010 Mar 15;49(6):2630-8. doi: 10.1021/ic901254j.

The thermal transformations of gamma-titanium phosphate, Ti(PO(4))(H(2)PO(4)) x 2 H(2)O, have been studied by thermal analyses (thermogravimetry (TG) and differential thermal analysis (DTA)) and variable-temperature (31)P magic-angle spinning (MAS)/CPMAS and 2D (31)P-(31)P spin-exchange NMR. The structure of this material...

Cite
García-Granda S, Khainakov SA, Espina A, et al. Revisiting the thermal decomposition of layered gamma-titanium phosphate and structural elucidation of its intermediate phases. Inorg Chem. 2010;49(6):2630-8doi: 10.1021/ic901254j.
García-Granda, S., Khainakov, S. A., Espina, A., García, J. R., Castro, G. R., Rocha, J., & Mafra, L. (2010). Revisiting the thermal decomposition of layered gamma-titanium phosphate and structural elucidation of its intermediate phases. Inorganic chemistry, 49(6), 2630-8. https://doi.org/10.1021/ic901254j
García-Granda, Santiago, et al. "Revisiting the thermal decomposition of layered gamma-titanium phosphate and structural elucidation of its intermediate phases." Inorganic chemistry vol. 49,6 (2010): 2630-8. doi: https://doi.org/10.1021/ic901254j
García-Granda S, Khainakov SA, Espina A, García JR, Castro GR, Rocha J, Mafra L. Revisiting the thermal decomposition of layered gamma-titanium phosphate and structural elucidation of its intermediate phases. Inorg Chem. 2010 Mar 15;49(6):2630-8. doi: 10.1021/ic901254j. PMID: 20170087.
Copy Download .nbib Format: NLM
Electronic structure of monolayer hexagonal boron nitride physisorbed on metal surfaces.

Physical review letters

Gamou Y, Kawai T, Nagashima A, Oshima C, Tejima N.
PMID: 10059764
Phys Rev Lett. 1995 Nov 20;75(21):3918-3921. doi: 10.1103/PhysRevLett.75.3918.

No abstract available.

Cite
Gamou Y, Kawai T, Nagashima A, et al. Electronic structure of monolayer hexagonal boron nitride physisorbed on metal surfaces. Phys Rev Lett. 1995;75(21):3918-3921doi: 10.1103/PhysRevLett.75.3918.
Gamou, Y., Kawai, T., Nagashima, A., Oshima, C., & Tejima, N. (1995). Electronic structure of monolayer hexagonal boron nitride physisorbed on metal surfaces. Physical review letters, 75(21), 3918-3921. https://doi.org/10.1103/PhysRevLett.75.3918
Gamou, et al. "Electronic structure of monolayer hexagonal boron nitride physisorbed on metal surfaces." Physical review letters vol. 75,21 (1995): 3918-3921. doi: https://doi.org/10.1103/PhysRevLett.75.3918
Gamou Y, Kawai T, Nagashima A, Oshima C, Tejima N. Electronic structure of monolayer hexagonal boron nitride physisorbed on metal surfaces. Phys Rev Lett. 1995 Nov 20;75(21):3918-3921. doi: 10.1103/PhysRevLett.75.3918. PMID: 10059764.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 218 entries